China NMPA Product Recall - surgical microscope

On February 28, 2019, Leica Microsystems (Shanghai) Trading Co., Ltd. proactively initiated a voluntary Class II recall concerning certain surgical microscopes. The decisive factor behind this action was the identification of a significant manufacturing flaw: insufficient tightening of the screws responsible for connecting the rocker arm to the main mirror within the M220 surgical microscope model. This structural deficiency presents a serious hazard, as there is a distinct possibility that the main mirror could unexpectedly detach and fall into the sterile surgical area during an ongoing medical procedure. Such an event carries a substantial risk of causing direct injury to the patient. The recall specifically targets surgical microscopes identified under Registration Certificate No.: 20172221149. This essential regulatory measure is conducted under the purview of the National Medical Products Administration (NMPA) and the Shanghai Food and Drug Administration, reflecting China's stringent oversight of medical device safety. The company's required action is to conduct this Class II recall, addressing the safety concern immediately. Further comprehensive details, including the precise models, specifications, and batch numbers of all affected products, are available for review in the official Medical Device Recall Event Report Form. This recall highlights the critical importance of robust quality control and manufacturing integrity in medical device production to safeguard patient well-being.